RDHL Stock Financials: Financial Performance and Reports

Period	FY-2023	FY-2022	FY-2021	FY-2020	FY-2019	FY-2018	FY-2017	FY-2016	FY-2015	FY-2014
Period Ended	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Operating Revenue	$6.51 M	$61.80 M	$85.76 M	$64.36 M	$6.29 M	$8.36 M	$4.01 M	$101,000.00	$3,000.00	$7.01 M
Cost of Revenue	$3.45 M	$33.34 M	$49.41 M	$36.89 M	$2.26 M	$2.84 M	$2.13 M	$30.54 M	$22.00 M	$1.05 M
Gross Profit	$3.06 M	$28.46 M	$36.35 M	$27.47 M	$4.03 M	$5.52 M	$1.88 M	-$30.44 M	-$22.00 M	$5.96 M
Gross Profit Ratio	0.47	0.46	0.42	0.43	0.64	0.66	0.47	-301.41	-7333	0.85
Research and Development Expenses	$3.52 M	$7.28 M	$29.50 M	$16.49 M	$17.42 M	$24.86 M	$32.97 M	$25.24 M	$17.77 M	$12.70 M
General & Administrative Expenses	$28.88 M	$54.97 M	$76.60 M	$25.38 M	$11.48 M	$7.51 M	$8.03 M	$5.40 M	$4.13 M	$4.01 M
Selling & Marketing Expenses	$2.10 M	$9.06 M	$11.39 M	$49.29 M	$18.33 M	$12.49 M	$12.01 M	$0.00	$0.00	$0.00
Selling, General & Administrative Expenses	$30.90 M	$64.03 M	$87.99 M	$74.66 M	$29.81 M	$19.99 M	$20.04 M	$5.40 M	$4.13 M	$4.01 M
Other Expenses	$8.60 M	$0.00	$0.00	$0.00	$0.00	$0.00	$845,000.00	$0.00	$100,000.00	-$100,000.00
Operating Expenses	$34.41 M	$71.31 M	$117.49 M	$91.15 M	$47.23 M	$44.85 M	$53.85 M	$30.64 M	$22.01 M	$16.61 M
Cost And Expenses	$37.86 M	$104.64 M	$166.89 M	$128.04 M	$49.49 M	$47.69 M	$55.98 M	$30.64 M	$22.01 M	$17.66 M
Interest Income	$94,000.00	$140,000.00	$51,000.00	$270,000.00	$1.34 M	$678,000.00	$6.51 M	$1.55 M	$1.12 M	$319,000.00
Interest Expense	$367,000.00	$41.33 M	$16.57 M	$12.76 M	$438,000.00	$167,000.00	$77,000.00	$375,000.00	$212,000.00	$383,000.00
Depreciation & Amortization	$1.98 M	$8.24 M	$18.14 M	$9.02 M	$2.55 M	$90,000.00	$81,000.00	$44,000.00	$36,000.00	$27,000.00
EBITDA	-$29.37 M	-$34.61 M	-$63.00 M	-$54.67 M	-$40.65 M	-$38.56 M	-$45.39 M	-$28.95 M	-$20.84 M	-$10.30 M
EBITDA Ratio	-4.51	-0.56	-0.73	-0.85	-6.46	-4.61	-11.33	-286.64	-6947.33	-1.47
Operating Income	-$31.35 M	-$42.84 M	-$81.14 M	-$63.68 M	-$43.20 M	-$39.33 M	-$51.97 M	-$30.54 M	-$22.00 M	-$10.65 M
Operating Income Ratio	-4.81	-0.69	-0.95	-0.99	-6.87	-4.7	-12.97	-302.41	-7334	-1.52
Total Other Income/Expenses Net	$55.21 M	-$28.83 M	-$16.61 M	-$12.49 M	$897,000.00	$274,000.00	$6.21 M	$898,000.00	$688,000.00	-$161,000.00
Income Before Tax	$23.85 M	-$71.67 M	-$97.74 M	-$76.17 M	-$42.30 M	-$38.82 M	-$45.54 M	-$29.37 M	-$21.09 M	-$10.71 M
Income Before Tax Ratio	3.66	-1.16	-1.14	-1.18	-6.72	-4.64	-11.37	-290.79	-7030	-1.53
Income Tax Expense	-$2.00	-$12.42 M	$16.57 M	$12.84 M	$1.33 M	$727,000.00	$6.29 M	$1.27 M	$900,000.00	$222,000.00
Net Income	$23.92 M	-$59.25 M	-$114.31 M	-$89.02 M	-$43.63 M	-$38.82 M	-$45.54 M	-$29.37 M	-$21.09 M	-$10.71 M
Net Income Ratio	3.67	-0.96	-1.33	-1.38	-6.94	-4.64	-11.37	-290.79	-7030	-1.53
EPS	3.68	-38.27	-98.27	-97.75	-58.78	-68	-104	-92	-76.13	-49.47
EPS Diluted	3.68	-38.27	-98.27	-97.75	-58.78	-68	-104	-92	-75.51	-49.12
Weighted Average Shares Out	$6.48 M	$1.55 M	$1.16 M	$910,690.00	$742,304.00	$570,882.00	$437,923.00	$309,299.00	$277,035.00	$216,525.00
Weighted Average Shares Out Diluted	$6.48 M	$1.55 M	$1.16 M	$910,690.00	$742,304.00	$570,882.00	$437,923.00	$319,239.00	$279,288.00	$218,055.00
Link

RedHill Biopharma Ltd. (RDHL) Financials

Select an alert type

Setup alert

Log In

Email Verification

Welcome to StockNews!

Create Your Account

Email Verification